Skip to main content

Table 1 Clinical characteristics in summary

From: Molecular pathological expression in malignant gliomas resected by fluorescein sodium-guiding under the YELLOW 560 nm surgical microscope filter

No

Age/sex

Symptoms/signs

Localization

Tumor size (cm3)

Pathology

% of resection

No. of biopsies

1

42/M

Seizure

RF

15.732

AA (WHO III)

100

4

2

71/F

Headache, somnolence

RT/P

126.759

GBM

100

2

3

49/M

Recurrent

RF

26.4

DA (partial AA, WHO III)

100

7

4

62/F

Aphasia, right prosopolegia

LF

68.04

GBM

100

3

5

48/F

Headache, left hemiparesis

LF/T/I

84.48

GBM

100

5

6

66/M

Headache, somnolence

LP/O

122.4

GBM

88.6

6

7

36/F

Headache, IICP

RF/T

28.7

GA (partial AA, WHO III)

100

2

8

50/F

Headache, left hemiparesis, IICP

RF

37.44

GBM

100

2

9

71/F

Left hemiparesis

LF/P

36

GBM

100

5

10

49/M

Seizure

RF

70.119

OD (WHO III)

100

5

11

35/M

Seizure

LF

49.02

OD (WHO III)

100

2

12

49/F

Recurrent

RF/T/I

94.875

rGBM

99.6

4

13

41/F

Headache, aphasia

LF/T/P

81.567

AA (WHO III)

100

3

14

61/F

Seizure

RF/T/I

21.06

DA (partial AA, WHO III)

100

2

15

26/F

Seizure

LF

44

OD (WHO III)

100

4

16

34/F

Recurrent

LF

13.888

rGBM

100

8

17

45/M

Seizure, left hemiparesis

RP

36

AA (WHO III)

100

2

18

32/M

Seizure, right tendon hyperreflexia

LF

13.32

GBM

100

3

  1. F female, M male, L left, R right, T temporal lobe, P parietal lobe, O occipital lobe, I insular lobe, GBM glioblastoma multiforme, rGBM reccurent glioblastoma multiforme, AA anaplastic astrocytoma, DA diffuse astrocytomas, OD oligodendrogliomas